The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Open accessAbstract
Pancreatic cancer presents with a dismal mortality rate and is in urgent need of methods for early detection with potential for timely intervention. All living cells, including cancer cells, generate exosomes. We previously discovered double stranded genomic DNA in exosomes derived from the circulation of pancreatic cancer patients, which enabled the detection of prevalent mutations associated with the disease. Here, we report a proof-of-concept study that demonstrates the potential clinical utility of circulating exosomal DNA for identification of KRASG12D and TP53R273H mutations in patients with pancreas-associated pathologies, including pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP) and intraductal papillary mucinous neoplasm (IPMN), and in healthy human subjects. In 48 clinically annotated serum samples from PDAC patients, digital PCR analyses of exosomal DNA identified KRASG12D mutation in 39.6% of cases, and TP53R273H mutation in 4.2% of cases. KRASG12D and TP53R273H mutations were also detected in exosomal DNA from IPMN patients (2 out of 7 with KRASG12D, one of which also co-presented with TP53R273H mutation). Circulating exosomal DNA in 5 out of 9 CP patients enabled the detection of KRASG12D mutation. In 114 healthy subject-derived circulating exosomal DNA, 2.6% presented with KRASG12D mutation and none with TP53R273H mutation. This study highlights the value of circulating exosomal DNA for a rapid, low-cost identification of cancer driving mutations. The identification of mutations in IPMN patients and healthy subjects suggests that liquid biopsies may allow potential assessment of cancer risk but with a cautionary note that detection of clinical cancer cannot be assumed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, liquid biopsy using circulating cfDNA proves valuable for diagnosis and monitoring.”
From Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer (2024) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study successfully detected KRASG12D and TP53R273H mutations in exosomal DNA from PDAC patients, showcasing the potential role of liquid biopsy [30].”
From Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. �., & Pantel, K. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3066 · Cited by 2,897
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
The biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,880
Self-citationBiogenesis and secretion of exosomes
Kowal, J., Tkach, M., & Théry, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.05.004 · Cited by 1,781
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Thakur, B. K., Zhang, H., Becker, A., Matei, I. R., Huang, Y., Costa‐Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., et al. (2014) · Cell Research · doi:10.1038/cr.2014.44 · Cited by 1,629
Genetics and biology of pancreatic ductal adenocarcinomaPreprint
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,611
Kahlert, C., Melo, S. A., Protopopov, A. I., Tang, J., Seth, S., Koch, M., Zhang, J., Weitz, J., Chin, L., Futreal, P. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.532267 · Cited by 1,058
Self-citationExosomes in tumor microenvironment influence cancer progression and metastasis
Kahlert, C., & Kalluri, R. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1020-6 · Cited by 888
Self-citationHuggett, J. F., Foy, C. A., Benes, V., Emslie, K., Garson, J. A., Haynes, R., Hellemans, J., Kubista, M., Mueller, R. D., Nolan, T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206375 · Cited by 859
Exosome mediated communication within the tumor microenvironment
Milane, L. S., Singh, A., Mattheolabakis, G., Suresh, M., & Amiji, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.029 · Cited by 752
Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., & Olivier, M. (2016) · Human Mutation · doi:10.1002/humu.23035 · Cited by 730
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 710
Genetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527
Taly, V., Pekin, D., Benhaïm, L., Kotsopoulos, S. K., Corre, D. L., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 511
Sausen, M., Phallen, J., Adleff, V., Jones, S., Leary, R. J., Barrett, M. T., Anagnostou, V., Parpart-Li, S., Murphy, D., Kay Li, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms8686 · Cited by 484
Löhr, M., Klöppel, G., Maisonneuve, P., Lowenfels, A. B., & Lüttges, J. (2005) · Neoplasia · doi:10.1593/neo.04445 · Cited by 343 · cited 1×
“a greater rate of KRAS mutation in our study; and this is also supported by other studies using cfDNA (5–20%)(16,29) as well as in analyses of pancreatic tissue.(8,9) In previous studies, KRAS”
ResultKobayashi, M., Ikeda, K., Saitoh, S., Suzuki, F., Tsubota, A., Suzuki, Y., Arase, Y., Murashima, N., Chayama, K., & Kumada, H. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11 · Cited by 245
Detection of K‐ras gene mutation by liquid biopsy in patients with pancreatic cancer
Kinugasa, H., Nouso, K., Miyahara, K., Morimoto, Y., Dohi, C., Tsutsumi, K., Kato, H., Matsubara, T., Okada, H., & Yamamoto, K. (2015) · Cancer · doi:10.1002/cncr.29364 · Cited by 239
Castells, A., Puig, P., Móra, J., Boadas, J., Boix, L., Urgell, E., Solé, M., Capellá, G., Lluı́s, F., Fernández‐Cruz, L., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.578 · Cited by 222
Lee, T. H., Chennakrishnaiah, S., Audemard, E. O., Montermini, L., Meehan, B., & Rak, J. W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.109 · Cited by 210
Lucas, F. A. S., Allenson, K., Bernard, V., Castillo, J., Kim, D. U., Ellis, K. E. S., Ehli, E. A., Davies, G. E., Petersen, J. L., Li, D., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv604 · Cited by 209
Z’graggen, K., Rivera, J. A., Compton, C. C., Pins, M., Werner, J., Castillo, C. F. F.-D., Rattner, D. W., Lewandrowski, K. B., Rustgi, A. K., & Warshaw, A. L. (1997) · Annals of Surgery · doi:10.1097/00000658-199710000-00010 · Cited by 200
p53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitis
Casey, G., Yamanaka, Y., Frieß, H., Kobrin, M. S., Lopez, M. E., Büchler, M. W., Beger, H. G., & Korc, M. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90168-9 · Cited by 166
Yu, J., Sadakari, Y., Shindo, K., Suenaga, M., Brant, A., Almario, J. A. N., Borges, M., Barkley, T., Fesharakizadeh, S., Ford, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311166 · Cited by 164
Lüttges, J., Reinecke-Lüthge, A., Möllmann, B., Menke, M. A. O. H., Clemens, A., Klimpfinger, M., Sipos, B., & Klöppel, G. (1999) · Virchows Archiv · doi:10.1007/s004280050428 · Cited by 127
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Polireddy, K., & Chen, Q. (2016) · Journal of Cancer · doi:10.7150/jca.14922 · Cited by 103
Brychta, N., Krahn, T., & von Ahsen, O. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257469 · Cited by 101
Zonta, E., Garlan, F., Pécuchet, N., Perez‐Toralla, K., Caën, O., Milbury, C. A., Didelot, A., Fabre, E., Blons, H., Laurent‐Puig, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159094 · Cited by 97
Berger, A. W., Schwerdel, D., Costa, I. G., Hackert, T., Strobel, O., Lam, S., Barth, T. F. E., Schröppel, B., Meining, A. G., Büchler, M. W., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.034 · Cited by 95
Yamada, T., Iwai, T., Takahashi, G., Kan, H., Koizumi, M., Matsuda, A., Shinji, S., Yamagishi, A., Yokoyama, Y., Tatsuguchi, A., et al. (2016) · Cancer Science · doi:10.1111/cas.12959 · Cited by 85
Uchiyama, Y., Nakashima, M., Watanabe, S., Miyajima, M., Taguri, M., Miyatake, S., Miyake, N., Saitsu, H., Mishima, H., Kinoshita, A., et al. (2016) · Scientific Reports · doi:10.1038/srep22985 · Cited by 74
Wada, K. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200007 · Cited by 68
Chang, D. K.-F., Grimmond, S. M., & Biankin, A. V. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.001 · Cited by 62
Histologic, Immunohistochemical, and Molecular Classification of 52 IPMNs of the Pancreas
Chadwick, B. E., Willmore‐Payne, C., Tripp, S. R., Layfield, L. J., Hirschowitz, S. L., & Holden, J. A. (2008) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31817c02c6 · Cited by 59
López, S. O., Garcı́a-Olmo, D. C., García‐Arranz, M., Guadalajara, H., Pastor, C., & García‐Olmo, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040484 · Cited by 47
Kaino, M., Kondoh, S., Okita, S., Hatano, S., Shiraishi, K., Kaino, S., & Okita, K. (1999) · Pancreas · doi:10.1097/00006676-199904000-00011 · Cited by 43
High-Throughput Mutation Profiling in Intraductal Papillary Mucinous Neoplasm (IPMN)
Lubezky, N., Ben‐Haim, M., Marmor, S., Brazowsky, E., Rechavi, G., Klausner, J. M., & Cohen, Y. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1411-8 · Cited by 32
Jang, J., Park, Y.-C., Song, Y. S., Lee, S. E., Hwang, D. W., Lim, C.-S., Lee, H. E., Kim, W. H., & Kim, S. (2009) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-009-0105-7 · Cited by 29
Manabe, F., Takeshima, H., & Akaza, H. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970301)79:5 · Cited by 25
K-ras and Dpc4 mutations in chronic pancreatitis: case series.
Hadžija, M. P., Korolija, M., Razumović, J. J., Pavković, P., Hadžija, M., & Kapitanović, S. (2007) · PubMed Central · Cited by 17
Research works printed but not linked: 2
- Popovic Hadzija M, 2007, Croat Med J, 48, 218
- 10.1200/jco/1999.17.2.578 · DOI
Cited by
Sorted by citations
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Self-citationExtracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,472
Exosome-Mediated Metastasis: Communication from a Distance
Wortzel, I., Dror, S., Kenific, C. M., & Lyden, D. C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.011 · Cited by 1,294
Exosomes in cancer development, metastasis, and immunity
Zhang, L., & Yu, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.004 · Cited by 870
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 864
Metadata
- Authors
- Yang, S., Che, S. P. Y., Kurywchak, P., Tavormina, J. L., Gansmo, L. B., Correa de Sampaio, P., Tachezy, M., Bockhorn, M., Gebauer, F., Haltom, A. R., Melo, S. A., LeBleu, V. S., & Kalluri, R.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- University Medical Center Hamburg-Eppendorf (DE)
- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal (I3S)
- Corresponding author
- Kalluri, Raghu
- ORCID
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2017-01-25
- Volume
- 18
- Issue
- 3
- Pages
- 158-165
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- PMC
- PMC5389423
- OpenAlex
- W2582660163
- Cited by
- 248
- References
- 42
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 24 · 2023: 27 · 2022: 26 · 2021: 37 · 2020: 38 · 2019: 33 · 2018: 20 · 2017: 13
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Biology & Therapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Texas MD Anderson Cancer Center ((CA016672))
- National Cancer Institute (P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- circulating exosomes, exosomal DNA, KRAS G12D mutation, pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasm, chronic pancreatitis, liquid biopsy, early cancer detection, cancer risk assessment, digital PCR
- MeSH terms
- DNA, DNA, Neoplasm, Humans, Mutation, Pancreatic Neoplasms, Case-Control Studies, Polymerase Chain Reaction, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Cell Line, Tumor, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
